Cochlear Investments Amends Nyxoah SA Stake Filing

TL;DR

Cochlear Investments Pty Ltd updated its stake in Nyxoah SA on 5/30/2024. Watch for more.

AI Summary

Cochlear Investments Pty Ltd, a subsidiary of Cochlear Ltd, has amended its Schedule 13D filing regarding Nyxoah SA. The filing, dated May 30, 2024, indicates a change in beneficial ownership. Cochlear Investments Pty Ltd is the filer, and Nyxoah SA is the subject company.

Why It Matters

This filing update from Cochlear Investments Pty Ltd signals a potential shift in the ownership structure or strategic interest in Nyxoah SA, which could impact the latter's stock performance and future direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant stake changes, which can lead to volatility and uncertainty for the subject company.

Key Players & Entities

• Cochlear Investments Pty Ltd (company) — Filer of the Schedule 13D/A
• Cochlear Ltd (company) — Parent company of Cochlear Investments Pty Ltd
• Nyxoah SA (company) — Subject company of the Schedule 13D/A
• Rob McGrory (person) — Group General Counsel & Company Secretary of Cochlear Limited

FAQ

Key Financial Figures

• $9.25 — d 540,540 Ordinary Shares at a price of $9.25 per share for an aggregate purchase pri
• $5.0 million — hare for an aggregate purchase price of $5.0 million. Cochlear Investments purchased the Ord

Filing Documents

• tm2415703d1_sc13da.htm (SC 13D/A) — 62KB
• 0001104659-24-066739.txt ( ) — 64KB

(c) of the Schedule 13D is hereby amended and supplemented as

Item 2(c) of the Schedule 13D is hereby amended and supplemented as follows: The name, present principal occupation, business address and citizenship of each director and executive officer of each of the Reporting Persons are set forth in Schedules A hereto and are incorporated herein by reference. ITEM 3 SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

of the Schedule 13D is hereby amended and supplemented as follows

Item 3 of the Schedule 13D is hereby amended and supplemented as follows: On May 28, 2024, Cochlear Investments purchased 540,540 Ordinary Shares at a price of $9.25 per share for an aggregate purchase price of $5.0 million. Cochlear Investments purchased the Ordinary Shares using cash on hand. To the extent required by Item 3, the information set forth or incorporated by reference in Items 4 and 5 is hereby incorporated herein by reference. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

of the Schedule 13D is hereby amended and

Item 5 of the Schedule 13D is hereby amended and supplemented by the following information: (a) – (b) As of the date hereof, Cochlear Investments directly owns 5,631,319 Ordinary Shares, representing 16.53% of the outstanding Ordinary Shares. Cochlear Limited is the parent company of Cochlear Investments. As a result, Cochlear Limited may be deemed to indirectly beneficially own the Ordinary Shares directly held by Cochlear Investments. The percentage of outstanding Ordinary Shares that may be deemed to be beneficially owned by each Reporting Person is set forth on line 13 of the cover sheet of hereof. Such percentage was calculated based on: (i) 28,682,635 Ordinary Shares outstanding as of March 31, 2024, plus 3,000 Ordinary Shares issued after March 31, 2024, in each case as stated in the Prospectus Supplement, plus (ii) 5,374,755 Ordinary Shares sold by the Issuer in a public offering of Ordinary Shares pursuant to the Prospectus Supplement on May 28, 2024. The Reporting Persons do not have the right to acquire any additional Ordinary Shares. (c) The reported share amounts for the Reporting Persons reflect amounts as of the date hereof. The Reporting Persons have not effected any transactions in the Ordinary Shares during the past 60 days, other than on May 28, 2024, Cochlear Investments acquired 540,540 Ordinary Shares from the Issuer at a price of $9.25 per share for an aggregate purchase price of $5.0 million. CUSIP No. B6S7WD106 Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: May 30, 2024 COCHLEAR INVESTMENTS PTY LTD By: /s/ Kristy Jo Name: Kristy Jo Title: Company Secretary COCHLEAR LIMITED By: /s/ Rob McGrory Name: Rob McGrory Title: Company Secretary SCHEDULE A Executive Officers and Directors of Cochlear Investments Pty Ltd Name and Position Present

View Full Filing

View this SC 13D/A filing on SEC EDGAR